Israel Roundup: Chip deal in the works; Rosetta and BigBand go public; biotech valley planned; Net porn bill advances; Web 2.0 funding; new software startups surge.
|
Chimerix, a developer of pills to treat smallpox, taps venture firms.
|
Report says that new legislation would bring big savings.
|
U.S. Presidential candidate proposes legislation that would help bring generic versions of biotech drugs to market.
|
JP Morgan attendees share their views, and biotech is king.
|
Strong sales of cancer, eye treatments help biotech giant beat analyst expectations by a nickel.
|
Biotech giant hangs tough, but faces questions about over-prescriptions and rival Roche.
|
IPO of biotech tools company would sever links to Acacia Research.
|
World Economic Forum summit in India emphasize need to monetize scientific innovation.
|
World Bank’s International Finance Corporation buys stake in Indian biotech company.
|
Biotech combination will expand sales of Xolair asthma drug.
|
Pharma giant pays hefty premium for biotech firm to get into growing RNAi market.
|
Far East Roundup: China wants bloggers to register their names; Japan offers number portability; South Korea gains in phone sales; North Korea makes dubious biotech claims.
|
Redmond giant is working with biotech firms on collaborative drug discovery.
|
German government agency will match funds to help early-stage ventures.
|
Ablynx scores one of the year’s top European biotech deals.
|
Meningitis program lowers costs, raises bar on collaboration.
|
Drug company Intranasal Therapeutics gets $39 million for a nose spray to ease battle wounds.
|
Despite Bush veto, work steams ahead.
|
Could frankencacao ensure a sweet future?
|
Page
1
of
8
|